Page last updated: 2024-09-03

zm 189154 and Body Weight

zm 189154 has been researched along with Body Weight in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chester, R; Dukes, M; Wakeling, AE; Yarwood, L	1
Ashby, J; Fenner-Crisp, P; Haseman, J; Kanno, J; Onyon, L; Owens, W	1

Other Studies

2 other study(ies) available for zm 189154 and Body Weight

Article	Year
Effects of a non-steroidal pure antioestrogen, ZM 189,154, on oestrogen target organs of the rat including bones. The Journal of endocrinology, 1994, Volume: 141, Issue:2 Topics: Animals; Binding, Competitive; Body Weight; Bone and Bones; Bone Density; Estrogen Antagonists; Female; Luteinizing Hormone; Organ Size; Ovarian Follicle; Ovariectomy; Ovary; Ovulation; Rats; Receptors, Estrogen; Tamoxifen; Tetrahydronaphthalenes; Uterus	1994
The OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: phase 1. Environmental health perspectives, 2001, Volume: 109, Issue:8 Topics: Animals; Biological Assay; Body Weight; Clinical Protocols; Dose-Response Relationship, Drug; Environmental Monitoring; Estrogen Antagonists; Estrogens; Ethinyl Estradiol; Female; Health Planning; Models, Animal; Organ Size; Program Evaluation; Rats; Reproducibility of Results; Sensitivity and Specificity; Tetrahydronaphthalenes; Toxicity Tests; Uterus	2001

Article

Year

Effects of a non-steroidal pure antioestrogen, ZM 189,154, on oestrogen target organs of the rat including bones.

The Journal of endocrinology, 1994, Volume: 141, Issue:2

Topics: Animals; Binding, Competitive; Body Weight; Bone and Bones; Bone Density; Estrogen Antagonists; Female; Luteinizing Hormone; Organ Size; Ovarian Follicle; Ovariectomy; Ovary; Ovulation; Rats; Receptors, Estrogen; Tamoxifen; Tetrahydronaphthalenes; Uterus

1994

The OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: phase 1.

Environmental health perspectives, 2001, Volume: 109, Issue:8

Topics: Animals; Biological Assay; Body Weight; Clinical Protocols; Dose-Response Relationship, Drug; Environmental Monitoring; Estrogen Antagonists; Estrogens; Ethinyl Estradiol; Female; Health Planning; Models, Animal; Organ Size; Program Evaluation; Rats; Reproducibility of Results; Sensitivity and Specificity; Tetrahydronaphthalenes; Toxicity Tests; Uterus

2001